Device Trial Radar · NCT06724146
Combined Treatment Sofwave and Pure Impact to Strength and Tone Muscles and Improve Lax Skin Appearance
Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
70
Actual
Start
Aug 5, 2024
Primary completion
Oct 1, 2026
Study completion Nov 1, 2026
Sponsor
- Lead sponsor
- Sofwave Medical LTDNot on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 9, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 25 years, up to 70 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Open-label, non-randomized, prospective, multi-center, self-controlled clinical study.
Conditions
- Skin Lax and Muscle Strength
Interventions
Sofwave and Pure ImpactDevice
The Sofwave System, comprised of an applicator and a console, generates high intensity, non-focused ultrasonic energy which can be delivered percutaneously to tissues. Pure Impact is an EMS module. This module is wirelessly connected to and controlled by the SofWave console. It functions independently from the existing ultrasound module. Pure Impact generates electrical impulses, which are delivered through electrodes on the skin in direct proximity to the muscles to be stimulated.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Improvement in the appearance of lax skinTime frame: 3 months post treatment follow-up visit
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Tennessee Clinical Research Center
Nashville, Tennessee
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.